These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 36327815)
1. Fibroblast-epithelial metabolic coupling in laryngeal cancer. Cao ZZ; Bao YY; Chen Z; Sheng LF; Zhou SH; Huang YP; Fan J Pathol Res Pract; 2022 Dec; 240():154177. PubMed ID: 36327815 [TBL] [Abstract][Full Text] [Related]
2. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Curry JM; Tuluc M; Whitaker-Menezes D; Ames JA; Anantharaman A; Butera A; Leiby B; Cognetti DM; Sotgia F; Lisanti MP; Martinez-Outschoorn UE Cell Cycle; 2013 May; 12(9):1371-84. PubMed ID: 23574725 [TBL] [Abstract][Full Text] [Related]
3. Stromal-epithelial metabolic coupling in gastric cancer: stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors. Zhao Z; Han F; He Y; Yang S; Hua L; Wu J; Zhan W Eur J Surg Oncol; 2014 Oct; 40(10):1361-8. PubMed ID: 24821064 [TBL] [Abstract][Full Text] [Related]
4. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4. Martinez-Outschoorn UE; Curry JM; Ko YH; Lin Z; Tuluc M; Cognetti D; Birbe RC; Pribitkin E; Bombonati A; Pestell RG; Howell A; Sotgia F; Lisanti MP Cell Cycle; 2013 Aug; 12(16):2580-97. PubMed ID: 23860378 [TBL] [Abstract][Full Text] [Related]
5. Cigarette Smoke Induces Metabolic Reprogramming of the Tumor Stroma in Head and Neck Squamous Cell Carcinoma. Domingo-Vidal M; Whitaker-Menezes D; Martos-Rus C; Tassone P; Snyder CM; Tuluc M; Philp N; Curry J; Martinez-Outschoorn U Mol Cancer Res; 2019 Sep; 17(9):1893-1909. PubMed ID: 31239287 [TBL] [Abstract][Full Text] [Related]
6. A reverse Warburg metabolism in oral squamous cell carcinoma is not dependent upon myofibroblasts. Jensen DH; Therkildsen MH; Dabelsteen E J Oral Pathol Med; 2015 Oct; 44(9):714-21. PubMed ID: 25420473 [TBL] [Abstract][Full Text] [Related]
7. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Whitaker-Menezes D; Martinez-Outschoorn UE; Lin Z; Ertel A; Flomenberg N; Witkiewicz AK; Birbe RC; Howell A; Pavlides S; Gandara R; Pestell RG; Sotgia F; Philp NJ; Lisanti MP Cell Cycle; 2011 Jun; 10(11):1772-83. PubMed ID: 21558814 [TBL] [Abstract][Full Text] [Related]
8. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers. Witkiewicz AK; Whitaker-Menezes D; Dasgupta A; Philp NJ; Lin Z; Gandara R; Sneddon S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP Cell Cycle; 2012 Mar; 11(6):1108-17. PubMed ID: 22313602 [TBL] [Abstract][Full Text] [Related]
9. Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy. Chen HL; OuYang HY; Le Y; Jiang P; Tang H; Yu ZS; He MK; Tang YQ; Shi M Cancer Med; 2018 Nov; 7(11):5339-5350. PubMed ID: 30306706 [TBL] [Abstract][Full Text] [Related]
10. High monocarboxylate transporter 4 protein expression in stromal cells predicts adverse survival in gastric cancer. Yan P; Li YH; Tang ZJ; Shu X; Liu X Asian Pac J Cancer Prev; 2014; 15(20):8923-9. PubMed ID: 25374230 [TBL] [Abstract][Full Text] [Related]
11. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation. Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149 [TBL] [Abstract][Full Text] [Related]
12. Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure. Andersen S; Solstad Ø; Moi L; Donnem T; Eilertsen M; Nordby Y; Ness N; Richardsen E; Busund LT; Bremnes RM Urol Oncol; 2015 Aug; 33(8):338.e9-17. PubMed ID: 26066969 [TBL] [Abstract][Full Text] [Related]
13. MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis. Kim HK; Lee I; Bang H; Kim HC; Lee WY; Yun SH; Lee J; Lee SJ; Park YS; Kim KM; Kang WK Mol Cancer Ther; 2018 Apr; 17(4):838-848. PubMed ID: 29483215 [TBL] [Abstract][Full Text] [Related]
14. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression. Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of monocarboxylate transporter 4 in patients with esophageal squamous cell carcinoma. Cheng B; Chen X; Li Y; Huang X; Yu J Oncol Rep; 2018 Nov; 40(5):2906-2915. PubMed ID: 30226548 [TBL] [Abstract][Full Text] [Related]
16. Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells. Diehl K; Dinges LA; Helm O; Ammar N; Plundrich D; Arlt A; Röcken C; Sebens S; Schäfer H Oncogene; 2018 Jan; 37(1):39-51. PubMed ID: 28846107 [TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of the expression of monocarboxylate transporter 4 in patients with right- or left-sided colorectal cancer. Abe Y; Nakayama Y; Katsuki T; Inoue Y; Minagawa N; Torigoe T; Higure A; Sako T; Nagata N; Hirata K Asia Pac J Clin Oncol; 2019 Apr; 15(2):e49-e55. PubMed ID: 30270512 [TBL] [Abstract][Full Text] [Related]
18. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome. Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922 [TBL] [Abstract][Full Text] [Related]
19. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration. Gao HJ; Zhao MC; Zhang YJ; Zhou DS; Xu L; Li GB; Chen MS; Liu J J Cancer Res Clin Oncol; 2015 Jul; 141(7):1151-62. PubMed ID: 25446815 [TBL] [Abstract][Full Text] [Related]
20. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4. Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]